Substance_Use_Prevention_in_the_United_States.docx CNL 501 Substance Use Prevention in the United States Grand Canyon University: CNL 501 Introduction Substance abuse is very m
...
Substance_Use_Prevention_in_the_United_States.docx CNL 501 Substance Use Prevention in the United States Grand Canyon University: CNL 501 Introduction Substance abuse is very much prevalent in the United States with most cases also having a secondary, or comorbid disorder. Substance abuse can affect any sex, gender, race, age, and so forth and does not discriminate; according to the American Addiction Centers (2021) in 2017 about nine percent of men, and five percent woman aged 12 and older had a substance abuse disorder. While the likelihood of abuse is more prevalent in males, women are just as prone to abuse when they do partake. Providing education and prevention groups to those who may not readily have access to these resources are a way to help each person develop healthy lifestyles and give them a sense of accountability. D.A.R.E Lynskey et al. (2003) believe that if prevention substance programs were utilized throughout the U.S substance abuse could be delayed by at least a couple years and could decrease for 1.5 million individuals. D.A.R.E is one the most well-known and heavily funded (over $750 million in funding since they™ve opened) school drug prevention-based program in the United States aimed towards young children. D.A.R.E, was developed by the LA school district in collaboration with the LAPD, and founded in 1991, stands for ˜Drug Abuse Awareness and Resistance Education™ and works to actively teach young children how to avoid the drug and stigmatization, with s. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]